Bonaventure Equity

Nalu Bio is a biotechnology company focused on producing cannabinoids, including CBD, through a proprietary chemistry-based platform rather than traditional plant extraction methods. This innovative approach allows Nalu Bio to create consistent and high-quality cannabinoid products that are free from THC, chemicals, and pesticides, while significantly reducing resource usage—utilizing 700 times less land, 70 times less water, and 14 times less energy compared to conventional methods. The company aims to set new standards in cannabinoid production for both consumer and pharmaceutical markets by ensuring purity and accessibility, thereby positioning itself to disrupt the traditional hemp extraction industry.

FloraWorks is a manufacturer and supplier of hemp-derived cannabinoids, focusing on the discovery and development of rare and novel cannabinoids for both commercial and therapeutic applications. The company collaborates with specialized biotech enterprises to create and patent scalable manufacturing pathways, ensuring that these cannabinoids are produced efficiently. FloraWorks conducts essential toxicology and efficacy research to facilitate the market entry of their products, which aim to address a variety of health conditions, including sleep disorders and Alzheimer's disease. By advancing cannabinoid research and manufacturing, FloraWorks plays a significant role in the evolving landscape of cannabinoid-based therapies and consumer products.

Nalu Bio is a biotechnology company focused on producing cannabinoids, including CBD, through a proprietary chemistry-based platform rather than traditional plant extraction methods. This innovative approach allows Nalu Bio to create consistent and high-quality cannabinoid products that are free from THC, chemicals, and pesticides, while significantly reducing resource usage—utilizing 700 times less land, 70 times less water, and 14 times less energy compared to conventional methods. The company aims to set new standards in cannabinoid production for both consumer and pharmaceutical markets by ensuring purity and accessibility, thereby positioning itself to disrupt the traditional hemp extraction industry.

LeafWorks Inc., founded in 2016 and based in Sebastopol, California, specializes in genetic testing services for natural product companies. The company helps clients accurately identify botanical raw materials through DNA testing, ensuring reliable labeling of products in the cannabis and herbal industries. LeafWorks offers a range of services including DNA sex tests, pathogen identification, feminized seed certification, cultivar registration, and genetic consulting. These services assist cannabis cultivators in preserving their genetic intellectual property, enhancing efficiency, and improving crop growth. Additionally, LeafWorks provides genomic resources to help clients understand the plants they are buying, selling, and growing in the cannabis and hemp markets.